Reblozyl 25 mg
Reblozyl 25 mg is a medicine authorised by Swissmedic under authorisation number 69592. The authorisation holder is Bristol-Myers Squibb SA. The medicinal product code is Biotechnological medicines and the dispensing category is A: Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly. First authorisation was granted on 21 May 2026 and the authorisation is limited until 20 May 2031. ATC code B03XA06 places the medicine in the group Antianemic preparations.
| Authorisation number | 69592 |
|---|---|
| Name | Reblozyl 25 mg |
| Full name | Reblozyl 25 mg, Pulver zur Herstellung einer Injektionslösung |
| Authorisation holder | Bristol-Myers Squibb SA |
| Medicinal product code | Biotechnological medicines |
| Dispensing category | A · Prescription, not repeatable |
| ATC code | B03XA06 |
| First authorisation | 21 May 2026 |
| Authorisation validity | 20 May 2031 |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Reblozyl 25 mg, Pulver zur Herstellung einer Injektionslösung | A | 21 May 2026 |
| 2 | Reblozyl 75 mg, Pulver zur Herstellung einer Injektionslösung | A | 21 May 2026 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 1 | 1 x 25 mg | Durchstechflasche(n) | B03XA06 | 06.07.3. | A |
| 2 | 1 x 75 mg | Durchstechflasche(n) | B03XA06 | 06.07.3. | A |
Scroll the table sideways
Other medicines from this authorisation holder
Frequently asked questions
Is Reblozyl 25 mg authorised in Switzerland?
Yes. Reblozyl 25 mg is authorised by Swissmedic under authorisation number 69592, data as of 01 September 2026. The authorisation is limited until 20 May 2031.
Which dispensing category does Reblozyl 25 mg have?
Reblozyl 25 mg is in dispensing category A. Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly.
Who is the authorisation holder of Reblozyl 25 mg?
The authorisation holder is Bristol-Myers Squibb SA. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.